GSK presents clinical trial results at 12th World Conference on Lung Cancer

Published: 2007-09-10 06:59:00

Updated: 2007-09-10 06:59:00

GlaxoSmithKline presented results from their clinical results of new medicines at the 12th World Conference on Lung Cancer being held in Seoul, Korea September 2-6, 2007.

The data presented at this symposium by world-renowned experts in the field highlighted GSK's innovative strategies, such a...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK